Because BPC-157 has not undergone the rigorous clinical trials needed for TGA approval (or FDA approval in the U.S.), it automatically lands on this list
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
If you have a desk job, you should be able to go back to work in about 10 to 14 days
For managing GI side effects common to both, our constipation treatment guide and related strategies apply broadly to GLP-1 therapy
Frequently Asked Questions Methylcobalamin injections may be prescribed during pregnancy if there is a confirmed Vitamin B12 deficiency, as maintaining adequate B12 levels is essential for fetal development
This simple tracking method eliminates any confusion about solution age and helps you adhere to the recommended 28-day usage window